HCV
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
Premium
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate
The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.
OraSure Technologies Q2 Revenues Drop 25 Percent, Miss Analysts Estimates
The firm said declines across most business areas were slightly offset by increases in sales of sample collection devices.
FDA Proposes Reclassification of HCV RNA, Antibody Tests
If the proposal is finalized, the tests will go through a less burdensome process to obtain marketing clearances.
OraSure Technologies Q4 Revenues Down 1 Percent
The firm saw strong increases in international HIV sales of its OraQuick HIV Self-Test product in the quarter.
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Jun 25, 2019
NeuMoDx Gets CE Mark on Hepatitis B and C Assays
Apr 25, 2019
Dec 18, 2018
Systaaq HBV Assay Receives CE Mark
Jul 5, 2018
Sep 11, 2017